This was further corroborated in a rat model with advanced CKD, in which immunohistochemistry demonstrated a strong expression of ACE2 in damaged proximal tubular cells which corresponded with lesions of COVID-19-induced AKI [72]. The gene discussed is ACE2; the disease is COVID-19.